OR WAIT null SECS
January 24, 2023
Video
Dermatology experts discuss BMI and other background comorbidities that can impact IL-23 inhibitors when treating plaque psoriasis.
Brad Glick, DO, AOCD, George Han, MD, PhD, and Neal Bhatia, MD, discuss year long term efficacy and safety data regarding the use of IL-23 inhibitors in patients with moderate to severe plaque psoriasis.
January 17, 2023
Dermatology experts discuss how IL-23 inhibitors fit into the current treatment landscape for plaque psoriasis.
George Han, MD, PhD, provides an overview of the long-term persistence of different biologic treatment options for plaque psoriasis.
